| Nome |
# |
|
Serum zonulin in patients with inflammatory bowel disease: a pilot study, file e27ce42e-91b3-2581-e053-d805fe0acbaa
|
1.180
|
|
Physiopathology of intestinal barrier and the role of zonulin, file e27ce42e-c4dd-2581-e053-d805fe0acbaa
|
902
|
|
Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis, file e27ce42d-ffc9-2581-e053-d805fe0acbaa
|
731
|
|
Risk of drug interactions and prescription appropriateness in elderly patients, file e27ce42e-d9db-2581-e053-d805fe0acbaa
|
608
|
|
Eosinophilic colitis: clinical review and 2020 update, file e27ce430-0316-2581-e053-d805fe0acbaa
|
589
|
|
Dupilumab to target interleukin 4 for inflammatory bowel disease? Hypothesis based on a translational message, file e27ce42e-c4db-2581-e053-d805fe0acbaa
|
578
|
|
Inflammation: a highly conserved, Janus-like phenomenon—a gastroenterologist’ perspective, file e27ce42e-4e14-2581-e053-d805fe0acbaa
|
534
|
|
The gut and the Inflammatory Bowel Diseases inside-out: the extra-intestinal manifestations, file e27ce42e-b886-2581-e053-d805fe0acbaa
|
493
|
|
Proctitis: a glance beyond inflammatory bowel diseases, file e27ce430-2f0b-2581-e053-d805fe0acbaa
|
474
|
|
Fecal calprotectin: beyond intestinal organic diseases, file e27ce42e-c975-2581-e053-d805fe0acbaa
|
462
|
|
Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn's disease: an observational study, file e27ce42f-4b41-2581-e053-d805fe0acbaa
|
400
|
|
Evaluation of a novel antioxidant formulation for the improvement of canine gastrointestinal health, file 69bfe565-71bb-46ac-8db4-861827fefdc5
|
393
|
|
A Concise History of Thiopurines for Inflammatory Bowel Disease: From Anecdotal Reporting to Treat-to-Target Algorithms, file e27ce42d-e91d-2581-e053-d805fe0acbaa
|
375
|
|
Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis, file e27ce42e-8e39-2581-e053-d805fe0acbaa
|
374
|
|
Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response, file e27ce42b-9ec6-2581-e053-d805fe0acbaa
|
358
|
|
Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents, file e27ce42e-a4c2-2581-e053-d805fe0acbaa
|
358
|
|
Risk factors of suspected spondyloarthritis among inflammatory bowel disease patients, file e27ce42e-6dd7-2581-e053-d805fe0acbaa
|
352
|
|
A randomized, double-blind, placebo-controlled pilot study to evaluate the efficacy and tolerability of a novel oral bioadhesive formulation for the treatment of nonerosive reflux disease-related symptoms, file e27ce431-9085-2581-e053-d805fe0acbaa
|
342
|
|
Circulating Zonulin is Related to Hepatic Necroinflammation in Patients with Non Alcoholic Fatty Liver Disease, file e27ce42f-5aa2-2581-e053-d805fe0acbaa
|
331
|
|
Is Helicobacter pylori the infectious trigger for headache?: A review, file e27ce42b-21dd-2581-e053-d805fe0acbaa
|
314
|
|
Management of Helicobacter pylori in Piedmont, Italy, file e27ce42e-bfdc-2581-e053-d805fe0acbaa
|
299
|
|
COVID-19: a user's guide, status of the art and an original proposal to terminate viral recurrence, file e27ce431-9dc2-2581-e053-d805fe0acbaa
|
291
|
|
Gut microbiota and chronic exercise in diabetic patients: not only bacteria, file e27ce42e-b884-2581-e053-d805fe0acbaa
|
278
|
|
ACG Clinical Guideline on Crohn’s Disease: A Point of View from Europe, file e27ce42e-29b4-2581-e053-d805fe0acbaa
|
268
|
|
Management of inflammatory bowel disease during COVID-19 pandemic, file e27ce430-3d0b-2581-e053-d805fe0acbaa
|
263
|
|
Pediatric epilepsy and psychiatric comorbidity: could celiac disease diagnosis improve the outcome?, file e27ce42d-474c-2581-e053-d805fe0acbaa
|
262
|
|
Differential diagnosis of pancreatic cysts: A prospective study on the role of intra-cystic glucose concentration, file e27ce430-7ba7-2581-e053-d805fe0acbaa
|
252
|
|
Adalimumab versus azathioprine to halt the progression of bowel damage in Crohn’s disease: application of Lémann Index, file e27ce42f-27c8-2581-e053-d805fe0acbaa
|
250
|
|
Diagnosis of Helicobacter pylori infection: a look into molecular aspects of urea breath test, file e27ce42e-7f46-2581-e053-d805fe0acbaa
|
246
|
|
Strategies for Helicobacter pylori eradication in the year 2020, file e27ce42f-e9b8-2581-e053-d805fe0acbaa
|
243
|
|
Is there a link between periampullary diverticula and biliopancreatic disease? An EUS approach to answer the question, file e27ce42e-79ce-2581-e053-d805fe0acbaa
|
241
|
|
Management of Pt1 tumours removed by endoscopy during colorectal cancer screening: Outcome and treatment quality indicators, file e27ce42d-404b-2581-e053-d805fe0acbaa
|
240
|
|
New Onset of Inflammatory Bowel Disease in Three Patients Undergoing IL-17A Inhibitor Secukinumab: A Case Series, file e27ce42d-c4ae-2581-e053-d805fe0acbaa
|
238
|
|
Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case Series, file e27ce430-c392-2581-e053-d805fe0acbaa
|
234
|
|
Vedolizumab for treatment of chronic refractory pouchitis: a systematic review with pool analysis, file e27ce42e-e7f3-2581-e053-d805fe0acbaa
|
232
|
|
Prevalence of Micronutrient Deficiency in Patients with Morbid Obesity Before Bariatric Surgery: What About Celiac Disease?, file e27ce42d-65c4-2581-e053-d805fe0acbaa
|
214
|
|
The therapy of chronic pouchitis, file e27ce42e-acc2-2581-e053-d805fe0acbaa
|
213
|
|
P21 | Oral Iron Supplementation with Iron Bisglycinate Chelate in Inflammatory Bowel Disease: A Retrospective Observational Study, file e27ce42e-5579-2581-e053-d805fe0acbaa
|
207
|
|
Helicobacter pylori eradication: poor medical compliance from East to West of the world, file e27ce42d-5949-2581-e053-d805fe0acbaa
|
204
|
|
Endoscopic ultrasound to diagnose pneumatosis cystoides intestinalis (with video), file e27ce42e-a30e-2581-e053-d805fe0acbaa
|
201
|
|
Role of bowel ultrasound as a predictor of surgical recurrence of Crohn's disease, file e27ce42e-b9ee-2581-e053-d805fe0acbaa
|
195
|
|
How ameliorate the adherence in patients with inflammatory bowel disease?, file e27ce42d-594d-2581-e053-d805fe0acbaa
|
184
|
|
Helicobacter pylori and proton pump inhibitor therapy: One diagnostic method is enough?, file e27ce42d-594b-2581-e053-d805fe0acbaa
|
182
|
|
P02.38 | Current practice of Gastroenterologists in the treatment of Helicobacter pylori infection in Italy: data from the Italian Registry on H. pylori treatment, file e27ce42d-4690-2581-e053-d805fe0acbaa
|
181
|
|
Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy, file e27ce42d-2549-2581-e053-d805fe0acbaa
|
177
|
|
Adalimumab trough levels predict Crohn's disease clinical course, file e27ce42d-5943-2581-e053-d805fe0acbaa
|
177
|
|
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study, file e27ce434-5e00-2581-e053-d805fe0acbaa
|
175
|
|
Outcomes of COVID-19 in 79 patients with IBD in Italy: An IG-IBD study, file e27ce42f-b577-2581-e053-d805fe0acbaa
|
174
|
|
Osteoporosis, osteopenia, and inflammatory bowel disease: lessons from a real‑world study, file e27ce42d-5128-2581-e053-d805fe0acbaa
|
172
|
|
Risk of incident melanoma in patients with inflammatory disease treated with anti-TNF: the Turin experience, file e27ce42e-acc0-2581-e053-d805fe0acbaa
|
171
|
|
Helicobacter pyloriinfection and asthma: Is there a direct or an inverse association? A meta-analysis, file e27ce42b-5b09-2581-e053-d805fe0acbaa
|
168
|
|
Periodontal health and coronary heart disease: a comment, file e27ce42d-65c1-2581-e053-d805fe0acbaa
|
167
|
|
OC. 12.4 PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE: ANALYSIS OF INTESTINAL OUTCOME AFTER LIVER TRANSPLANTATION, file e27ce42c-ddfa-2581-e053-d805fe0acbaa
|
165
|
|
Bariatric Surgery and Inflammatory Bowel Disease: a Role for Microbiota?, file e27ce42f-7782-2581-e053-d805fe0acbaa
|
161
|
|
The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets, file e27ce42d-3314-2581-e053-d805fe0acbaa
|
159
|
|
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study, file e27ce433-8ee5-2581-e053-d805fe0acbaa
|
157
|
|
Bone mineral density at diagnosis of celiac disease and after 1 year of gluten-free diet, file e27ce428-98b7-2581-e053-d805fe0acbaa
|
156
|
|
Prevalence of infectious agents in patients with systemic sclerosis: Defining the control group, file e27ce42b-28cc-2581-e053-d805fe0acbaa
|
153
|
|
Helicobacter pylori prevalence: Are the data totally reliable?, file e27ce42e-239f-2581-e053-d805fe0acbaa
|
153
|
|
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors, file 1194dde9-a7ab-4a89-b186-6a71769b5b5f
|
150
|
|
Microscopic colitis in patients with mild duodenal damage: A new clinical and pathological entity ("lymphocytic enterocolitis")?, file e27ce42a-d34c-2581-e053-d805fe0acbaa
|
150
|
|
Eosinophilic esophagitis and celiac disease, file e27ce42d-699d-2581-e053-d805fe0acbaa
|
150
|
|
The role of hepatic enzymes in Crohn’s disease, file e27ce42d-2532-2581-e053-d805fe0acbaa
|
147
|
|
AMOXYCILLIN AND METRONIDAZOLE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A 10-YEAR TREND IN TURIN, ITALY, file e27ce42b-7292-2581-e053-d805fe0acbaa
|
145
|
|
Association Between Gut Permeability and Insulin Resistance: Any Role for Zonulin in Patients with Non-Alcoholic Fatty Liver Disease?, file e27ce431-38ec-2581-e053-d805fe0acbaa
|
145
|
|
Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signalling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuate progression of oxazolone-induced colitis, file e27ce431-ffc7-2581-e053-d805fe0acbaa
|
140
|
|
Landing of the new coronavirus to Italian shores: It is mandatory to make the most from the Chinese experience, file e27ce430-b80d-2581-e053-d805fe0acbaa
|
138
|
|
Biosimilar CT-P13 in treating ulcerative colitis in the real world, file e27ce42d-3311-2581-e053-d805fe0acbaa
|
136
|
|
Food supplements, stress and gastrointestinal diseases, file e27ce42d-4de0-2581-e053-d805fe0acbaa
|
136
|
|
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care, file e27ce430-db6d-2581-e053-d805fe0acbaa
|
135
|
|
Inflammation in gastrointestinal disorders: prevalent socioeconomic factors, file e27ce42e-a9c7-2581-e053-d805fe0acbaa
|
134
|
|
Predictors of risk of fracture in inflammatory bowel diseases: a prospective study using FRAX score, file e27ce42f-e092-2581-e053-d805fe0acbaa
|
131
|
|
The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study, file e27ce430-db6b-2581-e053-d805fe0acbaa
|
127
|
|
P402 Interstitial and granulomatous lung disease in inflammatory bowel disease patients, file e27ce42c-6cf6-2581-e053-d805fe0acbaa
|
126
|
|
Efficacy of amoxycillin and clarithromycin-based triple therapy for Helicobacter pylori eradication: a 10-year trend in Turin, Italy, file e27ce42e-c7ca-2581-e053-d805fe0acbaa
|
122
|
|
History of Inflammatory Bowel Diseases, file e27ce42e-caea-2581-e053-d805fe0acbaa
|
121
|
|
Real time visualization may be advisable to exclude aspiration in patients undergoing capsule endoscopy examination, file e27ce42c-b351-2581-e053-d805fe0acbaa
|
120
|
|
Response to: Comment on "efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients", file e27ce42b-5401-2581-e053-d805fe0acbaa
|
119
|
|
2013 update on celiac disease and eosinophilic esophagitis, file e27ce42b-0c44-2581-e053-d805fe0acbaa
|
117
|
|
A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy, file e27ce432-79b6-2581-e053-d805fe0acbaa
|
117
|
|
Laboratory evidence of Helicobacter species infection in hepatocellular carcinoma, file e27ce42d-1bf1-2581-e053-d805fe0acbaa
|
113
|
|
On Inverse Association between Helicobacter pylori Gastritis and Microscopic Colitis: The European Data, file e27ce42d-2398-2581-e053-d805fe0acbaa
|
109
|
|
Features of inflammatory bowel disease followed in a second level center in Northern Italy, file e27ce42d-253f-2581-e053-d805fe0acbaa
|
109
|
|
Gastric emptying and related symptoms in patients treated with buspirone, amitriptyline or clebopride: a "real world" study by 13C-octanoic acid breath test, file e27ce42f-03ad-2581-e053-d805fe0acbaa
|
109
|
|
Infections and stroke: Which potential pathogenic mechanism?, file e27ce42d-d892-2581-e053-d805fe0acbaa
|
108
|
|
Adnexal localization of crohn’s disease and recurrent massive ovary cysts, file e27ce42e-c7ce-2581-e053-d805fe0acbaa
|
104
|
|
Comment #2 on "First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin", file e27ce42d-c4aa-2581-e053-d805fe0acbaa
|
102
|
|
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients, file e27ce42e-885a-2581-e053-d805fe0acbaa
|
100
|
|
Helicobacter pylori infection and ischemic heart disease: could experimental data lead to clinical studies?, file e27ce42e-66ef-2581-e053-d805fe0acbaa
|
99
|
|
Comment on "Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp", file e27ce42c-700e-2581-e053-d805fe0acbaa
|
95
|
|
Comment on Helicobacter pylori seroprevalence and the occurrence and severity of psoriasis, file e27ce42e-a17a-2581-e053-d805fe0acbaa
|
95
|
|
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report, file e27ce430-55fd-2581-e053-d805fe0acbaa
|
94
|
|
Helicobacter pylori eradication: the relevance of a periodic update, file e27ce42e-064c-2581-e053-d805fe0acbaa
|
92
|
|
Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis, file e27ce431-06a7-2581-e053-d805fe0acbaa
|
91
|
|
The first-line treatment of Helicobacter pylori infection in Piedmont in the year 2017, file e27ce42d-675b-2581-e053-d805fe0acbaa
|
89
|
|
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review, file e27ce433-b51f-2581-e053-d805fe0acbaa
|
89
|
|
Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients, file e27ce42d-c9dd-2581-e053-d805fe0acbaa
|
88
|
|
Does Helicobacter pylori infection increase the risk of adult-onset asthma?, file e27ce42d-2eb2-2581-e053-d805fe0acbaa
|
87
|
|
Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma, file e27ce431-b21b-2581-e053-d805fe0acbaa
|
87
|
|
Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy?, file e27ce42d-244b-2581-e053-d805fe0acbaa
|
86
|
| Totale |
23.003 |